Ramin Farzaneh-Far, Chief Medical Officer at Ra Pharmaceuticals, Inc. (RARX), sold 10,595 shares at $22.04 ($231K) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Open-market sale of $231k RARX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.41 | 3,411 | $73K | 31.6% |
| 2 | $22.04 | 7,184 | $158K | 68.4% |
| Total | $21.84 avg | 10,595 | $231K | 100% |
| Filing → |
| RARX | SELL | 2020-01-16 | $995K | — | Filing → |
| RARX | SELL | 2019-12-18 | $1.0M | — | Filing → |
| RARX | SELL | 2019-12-18 | $500K | — | Filing → |